They have barely enough money to cover the exorbitant wage bill for the next 2 years and a cr at 15 year lows will see it stay at a 3c range.
Then there is no guarantees that the low dose that has been approved will work anyway. Clearly the fda had concerns about toxicity which has plagued the whole antisense platform.
News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study, page-18
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
